Ohio State University has signed up to a spinout-focused life sciences venture vehicle run by regional firm Rev1 Ventures that stands at three times the size of its precursor.

Ohio State University (OSU) and Nationwide Children’s Hospital (NCH) have joined seed-stage venture firm Rev1 Ventures as investors in a new $15m fund geared towards life sciences spinouts and other businesses. Rev1 Catalyst Fund II aims to supply critical-stage funding and assistance to healthcare projects surrounding Columbus, central Ohio, home to both of its limited…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.